Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 18:07 (1362 d 17:53 ago) – Posting: # 21893
Views: 7,470

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,034 posts in 4,835 threads, 1,647 registered users;
34 visitors (0 registered, 34 guests [including 6 identified bots]).
Forum time: 12:00 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5